Activity Overview
This educational activity is an archive of the live conference held on July 11 – 12, 2026.
Target Audience
This educational activity is directed toward hematologists, medical oncologists, and fellows involved in the treatment and management of patients with hematologic malignancies. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of hematologic malignancies may also participate.
Learning Objectives
- Develop longitudinal treatment strategies that incorporate sequencing across lines of therapy, prior treatment exposure, and anticipated next-line options
- Integrate multidisciplinary care strategies to further optimize the treatment of hematologic malignancies
Saad Z. Usmani, MD, MBA, FACP, FASCO
Professor
Chief, Myeloma Service
Memorial Sloan Kettering Cancer Center
New York, NY
Charalampos Charalampous, MD
PGY-4
Hematology-Oncology Fellow
Memorial
Sloan Kettering Cancer Center
New York, NY
Jae H. Park, MD
Chief,
Cellular Therapy Service
Attending
Physician
Department
of Medicine
Memorial
Sloan Kettering Cancer Center
New
York, NY
Ran Reshef, MD, MSc
Professor of Medicine at CUMC
Director, Translational Research, Blood and
Marrow Transplantation Program
Director, Cell Therapy Program
Columbia University Irving Medical Center
New York, NY
Shambavi Richard, MD
Associate Professor of Medicine
Director of Myeloma CAR T Research Program
and Stem Cell Transplant
Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, NY
Please click here to view disclosures for faculty and the staff of Physicians’ Education Resource®.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here